Utilizing preclinical models to develop targeted therapies for rare central nervous system cancers. Arakaki AKS, Szulzewsky F, Gilbert MR, Gujral TS, et al. Neuro Oncol 2021;23.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Arakaki AKS, Szulzewsky F, Gilbert MR, Gujral TS, et al. Utilizing preclinical models to develop targeted therapies for rare central nervous system cancers. Neuro Oncol 2021;23.
PMID: 34725698